{"id":"tp-39762","type":"article-newspaper","title":"Eli Lilly Posts 79.3% Response Rate for Ovarian Cancer Drug","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/39762","datePublished":"2026-10-24T07:41:30.000Z","dateModified":"2026-10-24T07:41:30.000Z","language":"en","abstract":"Twenty-three of 29 women with measurable disease responded; the full cohort included 33. Lilly shares fell 2.54% on Oct. 23, before the release early Oct. 24.","section":"Business","references":[]}